l-carnitine and kennedy disease What is Kennedy's l-carnitine alleviates synovitis in knee

Cell (2010) 140:93550

Circadian inflammation patterns Inflammatory cytokine diurnal rhythms: IL-6: Peaks 6-8 AM (early morning highest) TNF-: Peaks 6-8 AM (follows similar pattern) IL-1: Peaks morning to midday Cortisol: Peaks 8 AM (anti-inflammatory counter-response) CRP: Peaks around 6 AM Why inflammation peaks morning: Circadian clock genes regulate immune function Cortisol awakening response (CAR) triggers Evolutionary advantage (ready for daytime threats) Sympathetic nervous system activation Pro-inflammatory state to prepare for activity Evening/night inflammation patterns: Inflammatory markers lowest 8 PM - midnight Parasympathetic dominance (rest/digest) Repair and regeneration processes activate Reduced cytokine production Anti-inflammatory environment Implications for KPV timing: Individual variation: Some people more inflammatory at night (rare) Shift workers have altered circadian rhythms Chronic stress disrupts normal patterns Autoimmune conditions may not follow typical rhythms Track personal patterns for optimization Gut healing and sleep cycles Nocturnal gut healing processes: Reduced digestive burden: No food intake during sleep Enhanced repair: Cellular regeneration peaks during sleep Tight junction restoration: Gut barrier repair occurs Stem cell activation: Intestinal stem cells proliferate Immune modulation: Regulatory T-cells active Why evening KPV might support gut healing: KPV present during peak healing window (sleep) Anti-inflammatory during nocturnal repair Supports tight junction integrity overnight Reduces inflammation while gut rests Synergizes with natural healing processes Fasted state benefits: KPV absorption better on empty stomach Morning before eating = fasted Night before bed = fasted (3+ hours post-dinner) Both times optimal for absorption Avoid dosing with or right after meals Gut motility considerations: Digestive motility slows during sleep May increase mucosal contact time (good for oral KPV) Longer exposure to intestinal lining Enhanced local effects possible Theoretical advantage for IBD treatment Research evidence (limited): No specific studies on KPV timing Extrapolated from general gut healing principles Clinical observations suggest evening dosing effective Morning dosing also works (anti-inflammatory) Individual experimentation recommended See peptides for gut health guide

However, the transgenic F1 larvae carrying LMNA (E358K), LMNA (R453W), and LMNA (A539V) variants exhibited significantly slower swim speed compared to the LMNA (WT) (Fig

This distinguishes it from better-known compounds such as semaglutide (Ozempic/Wegovy), which targets only the GLP-1 receptor, and from tirzepatide (Mounjaro/Zepbound), which is a dual GLP-1/GIP agonist

These modifications dramatically reduce binding to IGF binding proteins (IGFBP-1 through IGFBP-6), increasing the proportion of bioavailable peptide for receptor interaction in cell-culture systems

Loss of appetite or upset stomach (nausea)